The dietary compound luteolin inhibits pancreatic cancer growth by targeting BCL-2
Z Li, Y Zhang, L Chen, H Li - Food & function, 2018 - pubs.rsc.org
Overexpression of the prosurvival protein BCL-2 contributes to malignant cell initiation,
progression and resistance to treatment. Agents that function as its natural antagonists …
progression and resistance to treatment. Agents that function as its natural antagonists …
Dietary compound luteolin inhibits pancreatic cancer growth by targeting BCL-2
Z Li, Y Zhang, L Chenb, H Lia - scholar.archive.org
SUPPLEMENTARY MATERIAL Page 1 SUPPLEMENTARY MATERIAL Dietary compound
luteolin inhibits pancreatic cancer growth by targeting BCL-2 Zhimei Li,a Yiyuan Zhang,a Lixia …
luteolin inhibits pancreatic cancer growth by targeting BCL-2 Zhimei Li,a Yiyuan Zhang,a Lixia …
The dietary compound luteolin inhibits pancreatic cancer growth by targeting BCL-2
Z Li, Y Zhang, L Chen, H Li - Food & Function, 2018 - cir.nii.ac.jp
The dietary compound luteolin inhibits pancreatic cancer growth by targeting BCL-2 | CiNii
Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 …
Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 …
The dietary compound luteolin inhibits pancreatic cancer growth by targeting BCL-2.
Z Li, Y Zhang, L Chen, H Li - Food & Function, 2018 - europepmc.org
Overexpression of the prosurvival protein BCL-2 contributes to malignant cell initiation,
progression and resistance to treatment. Agents that function as its natural antagonists …
progression and resistance to treatment. Agents that function as its natural antagonists …
The dietary compound luteolin inhibits pancreatic cancer growth by targeting BCL-2
Z Li, Y Zhang, L Chen, H Li - Food & function, 2018 - pubmed.ncbi.nlm.nih.gov
Overexpression of the prosurvival protein BCL-2 contributes to malignant cell initiation,
progression and resistance to treatment. Agents that function as its natural antagonists …
progression and resistance to treatment. Agents that function as its natural antagonists …